UBA80 and UBA52 fine-tune RNF168-dependent histone ubiquitination and DNA repair
Journal of Biological Chemistry · 2023-08 · 299 (8) · 105043
DOI: 10.1016/j.jbc.2023.105043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-08. Verfasst von Seong-Ok Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA; Department o…. Hauptthemen laut MEDLINE: DNA Repair, Histones, Nucleosomes, Ribosomal Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The ubiquitin signaling pathway is crucial for the DNA damage response pathway. More specifically, RNF168 is integral in regulating DNA repair proteins at damaged chromatin. However, the detailed mechanism by which RNF168 is regulated in cells is not fully understood. Here, we identify the ubiquitin-ribosomal fusion proteins UBA80 (also known as RPS27A) and UBA52 (also known as RPL40) as interacting proteins for H2A/H2AX histones and RNF168. Both UBA80 and UBA52 are recruited to laser-induced micro-irradiation DNA damage sites and are required for DNA repair. Ectopic expression of UBA80 and UBA52 inhibits RNF168-mediated H2A/H2AX ubiquitination at K13/15 and impairs 53BP1 recruitment to DNA lesions. Mechanistically, the C-terminal ribosomal fragments of UBA80 and UBA52, S27A and L40, respectively, limit RNF168-nucleosome engagement by masking the regulatory acidic residues at E143/E144 and the nucleosome acidic patch. Together, our results reveal that UBA80 and UBA52 antagonize the ubiquitination signaling pathway and fine-tune the spatiotemporal regulation of DNA repair proteins at DNA damage sites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA; Department of Radiation Oncology, College of Medicine, University of Arkansas for…
- Department of Radiation Oncology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA; Department of Biochemistry and Molecular Biology, College of Medicine, University of Arkans…
- Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Radiation Oncology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA; Department of Radiation Oncology, University of Texas Health Science Center at San Antonio,…
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- American Cancer Society
- National Cancer Institute
- National Institute of General Medical Sciences
- University of Arkansas for Medical Sciences
Zitieren
APA
Lee, S. O., Kelliher, J. L., Song, W., Tengler, K., Sarkar, A., Dray, E., & Leung, J. W. C. (2023). UBA80 and UBA52 fine-tune RNF168-dependent histone ubiquitination and DNA repair. Journal of Biological Chemistry, 299(8), 105043. https://doi.org/10.1016/j.jbc.2023.105043
Vancouver
Lee SO, Kelliher JL, Song W, Tengler K, Sarkar A, Dray E, et al. UBA80 and UBA52 fine-tune RNF168-dependent histone ubiquitination and DNA repair. Journal of Biological Chemistry. 2023;299(8):105043. doi:10.1016/j.jbc.2023.105043
BibTeX
@article{Lee2023,
author = {Lee, Seong-Ok and Kelliher, Jessica L and Song, Wan and Tengler, Kyle and Sarkar, Aradhan and Dray, Eloise and Leung, Justin W C},
title = {UBA80 and UBA52 fine-tune RNF168-dependent histone ubiquitination and DNA repair},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {8},
pages = {105043},
doi = {10.1016/j.jbc.2023.105043}
}
EUVIMED